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Introduction
Acute events such as pneumonia, inhalational injury, trauma, or sepsis often damage the lung epitheli-
um, which consequently can impede the primary function of  the lung exchanging oxygen and carbon 
dioxide. Repair of  the epithelium after injury is necessary to restore homeostasis, and current views 
propose that the immune system plays an important role in enhancing barrier function and promoting 
resolution (1–4). Resolution is an actively regulated program involving clearance of  edema fluid, removal 
of  apoptotic cells, matrix remodeling, and repair of  alveolar epithelium (4–8). The mechanisms underly-
ing the resolution process are not well characterized (2).
Foxp3+ Tregs are a distinct population of  CD4+ lymphocytes, identified by their expression of  the 
transcription factor Forkhead homeobox protein-3 (FOXP3). This population suppresses and downregu-
lates immune responses in allergic and autoimmune diseases (9, 10).
Tregs serve a central role in suppressing the immune response and facilitating resolution in 
experimental acute lung injury (ALI) (11, 12). They contribute to tissue repair through the expres-
sion of  the growth factor amphiregulin (AREG) (13, 14). Patients with acute respiratory distress 
syndrome (ARDS) have increased numbers of  Tregs in the bronchoalveolar compartment (12, 15). 
Our prior studies demonstrate that Tregs enhance alveolar epithelial proliferation after injury in vivo 
and that Tregs directly promote AT2 proliferation in vitro, in part by a contact-independent mecha-
nism, through the expression of  keratinocyte growth factor (KGF) (16). However, the mechanisms 
by which Tregs facilitate resolution are far from clear and likely dependent on the type of  injury, 
the microenvironment, and the target cells in question. In the study presented here, we sought to 
identify potential differences in lung-specific Treg transcript expression profiles during a time of  
resolution from lung injury, as compared with Tregs from uninjured lungs and with Tregs obtained 
from another tissue site (splenic Tregs) during resolution.
Recovery from acute lung injury (ALI) is an active process. Foxp3+ Tregs contribute to recovery 
from ALI through modulating immune responses and enhancing alveolar epithelial proliferation 
and tissue repair. The current study investigates Treg transcriptional profiles during resolution 
of ALI in mice. Tregs from either lung or splenic tissue were isolated from uninjured mice or mice 
recovering from ALI and then examined for differential gene expression between these conditions. 
In mice with ALI, Tregs isolated from the lungs had hundreds of differentially expressed transcripts 
compared with those from the spleen, indicating that organ specificity and microenvironment are 
critical in Treg function. These regulated transcripts suggest which intracellular signaling pathways 
modulate Treg behavior. Interestingly, several transcripts having no prior recognized function in 
Tregs were differentially expressed by lung Tregs during resolution. Further investigation into 2 
identified transcripts, Mmp12 and Sik1, revealed that Treg-specific expression of each plays a role 
in Treg-promoted ALI resolution. This study provides potentially novel information describing the 
signals that may expand resident Tregs, recruit or retain them to the lung during ALI, and modulate 
their function. The results provide insight into both tissue- and immune microenvironment–specific 
transcriptional differences through which Tregs direct their effects.
The established lung injury model of  intratracheal LPS–induced (i.t. LPS–induced) injury, which 
has been well characterized for eliciting alveolar epithelial damage and a neutrophilic influx, elicits a 
very reproducible inflammatory response (11, 17, 18). Moreover, i.t. LPS administration at this dosage 
is followed by a consistent and uniform resolution process (11). Therefore, this model is well suited for 
studying transcriptional changes when studies require a combination of  multiple samples to obtain ade-
quate numbers for downstream analysis.
Data herein demonstrate that, during ALI resolution, Tregs regulate their expression of  genes such 
as Areg, Ctla4, Icos, Il10, Itgae, and Sgk1, known to be important for their function in immune suppres-
sion or tissue repair (11, 13, 19–21). Several chemokines, cytokines, and chemokine and cytokine recep-
tors were also differentially expressed, including Cxcl16, Ccr5, Ccr2, Cxcr4, Cxcr5, Cxcr6, Ifngr2, Il1rl1, 
and Il18r1. These observations provide insight into the signals that may expand resident Tregs, recruit 
them from distant sites or retain them in the lung during ALI. Interestingly, other transcripts such as 
C3ar1, C5ar1, Mmp12, and Sik1, which have little to no known role in Treg function, were differentially 
expressed during resolution of  injury. Studies pursuing the expression and function of  MMP12 show that 
Treg-expressed MMP12 may either minimize the recruitment of  neutrophils or facilitate their clearance. 
Additional investigation into the function of  SIK1 in Tregs demonstrates that absence of  Sik1 affects Treg 
number and their expression of  the integrin CD103 (αEβ7) during ALI resolution.
These studies provide insight into both the tissue- and immune microenvironment–specific transcrip-
tional responses by which Tregs direct their suppressive and tissue-reparative effects during resolution of  
experimental ALI. Our results underline the complexity of  Treg function in the processes of  tissue repair 
following lung injury.
Results
Treg population increases in the lung during resolution of  LPS-induced ALI. Previous reports demonstrate that 
Treg expansion in the lung peaks at 7 days after injury in this LPS model of  ALI in mice (11, 12). 
To quantify the change in the number of  Tregs before and during the resolution phase of  injury, we 
employed Foxp3EGFP mice, in which the gene for enhanced GFP (EGFP) was inserted downstream of  the 
endogenous Foxp3 locus, resulting in fluorescence of  all Foxp3-expressing cells (22).
The data show that, by day 7 after injury, male mice exposed to LPS have begun to recover from their 
weight loss due to the injury, which nadirs at day 4 after LPS (Figure 1A). Total lung cell count in the enzy-
matically digested single cell suspensions, total bronchoalveolar lavage (BAL) cell numbers, and BAL total 
protein concentration at days 7 and 10 after injury remain elevated compared with uninjured control mice 
(Figure 1, B–D) (11). The number of Foxp3+ cells was determined in both the bronchoalveolar space and 
in single cell suspensions generated from whole lung digests following lung lavage (Figure 1, E and F). The 
number of lavageable Tregs in the airspace increases significantly at days 7 and 10 (Figure 1E). In the lung 
digests made following lavage, the number of Tregs increases approximately 3.7-fold (Figure 1F) during ALI 
resolution at day 7 after injury, and by 10 days, the numbers begin to trend downward, similar to a prior 
report utilizing a different Foxp3 reporter strain (11). Comparison of Figure 1E with Figure 1F demonstrates 
that almost all (>99%) of the lung Tregs are present in the lung digest and not lavageable. The percentage 
of Foxp3+ cells within the total CD4+ cell population also increases during resolution at days 7 and 10 after 
injury in the lung cell suspensions (Figure 1G). These observations demonstrate that Tregs are present in 
uninjured lungs, increase within both the lavageable alveolar space and the lung parenchyma during ALI res-
olution, and peak at 7 days after LPS in this Treg transgenic reporter mouse line, similarly to WT mice (11).
Lung and spleen Tregs have distinct transcriptomes during ALI resolution. To determine potential changes 
in Treg transcriptional expression during experimental ALI, we performed transcriptome profiling of  
sorted Tregs. Three sets of  Tregs were examined: (a) Lung Tregs sorted from uninjured lungs (control 
lung Tregs), (b) lung Tregs sorted at 7 days after LPS injury (resolving lung Tregs), and (c) splenic Tregs 
sorted at 7 days after LPS injury (resolving splenic Tregs) from the same mice as the resolving lung Tregs. 
To obtain adequate numbers of  Tregs for mRNA analysis, combining single cell suspensions from mul-
tiple mice was required before sorting for each condition and replicate (n = 15–27 mice/experimental 
replicate). This study utilized both male and female mice age 8–12 weeks, and 3 replicates were per-
formed for each of  the 3 conditions. The gating scheme and postsorting percentages are shown in Sup-
plemental Figure 1 (supplemental material available online with this article; https://doi.org/10.1172/
jci.insight.124958DS1). The purity of  the Treg sets was greater than 93% after cell sorting. The mortality 
following LPS injury was 5% (data not shown). The change in body weight as the injured mice recovered 
showed that the mice were recovering by 7 days, when the Tregs were isolated (Figure 2A).
For transcriptome analysis, we employed a statistical methodology based on linear models with 
empirical Bayes statistics, available from the limma package, to calculate moderated t-statistics and to 
identify differentially regulated transcripts between Treg sets (23, 24). Such an approach is analogous 
to shrinking estimated sample variances toward a pooled estimate among multiple genes, which was 
demonstrated to be more robust and improve inferences at both the gene and gene set levels (23, 25), 
particularly in small data sets. The array data set expression values are normalized and then analyzed 
with the limma package as an integrated whole, as previously described (23, 24). We identified 1,599 
differentially expressed transcripts between Treg sets using this method when filtering at an adjusted P < 
0.05 and a fold change >2 (transcripts listed in Supplemental Tables 1–3).
Principal component analysis (PCA) of  gene expression of  sorted Tregs between the 3 condi-
tions showed that the top 3 principal components accounted for 52% of  the variance in between Treg 
sets (Figure 2B). The numbers of  transcripts that were up- or downregulated for each comparison 
are shown in Table 1.
A Venn diagram demonstrates overlap of differentially expressed transcripts (Figure 2C and Supplemen-
tal Tables 1–3). Tregs from lungs at 7 days after injury differentially expressed 80 transcripts coding for 78 
unique genes, when compared with the expression profile of Tregs from control lungs (resolving lung Tregs 
vs. control lung Tregs) (Figure 2C; transcripts listed in Supplemental Table 1). Tregs from lungs differentially 
expressed 1,033 transcripts compared with the Tregs from spleens of the same mice at 7 days after injury 
(resolving lung Tregs vs. resolving splenic Tregs) (Figure 2C; transcripts listed in Supplemental Table 2).
Unsupervised hierarchical clustering of  the 1,599 transcripts demonstrated that each experimental 
array sample clustered first into their respective location (lung compared with spleen) and then by treat-
ment (control lung Tregs compared with resolving lung Tregs) (Figure 2D). The heatmap depicts the 
Figure 1. Foxp3+ Tregs increase in the lung during resolution of ALI. Male Foxp3EGFP mice were challenged with LPS (3 mg/kg) intratracheally. (A) Body 
weight relative to baseline measured daily before and after injury (n = 15–47 per time point). (B–D) Total lung cell count in the lung digest (B), total cell 
counts in the bronchoalveolar lavage (BAL) (C), and BAL total protein concentration (D) were determined in Foxp3EGP mice, either unchallenged or after 
treatment with LPS (n = 10–22 per time point; combined from 2–3 separate experiments). (E–F) The number of GFP+ cells in the BAL (E) or lung digests 
(F) of unchallenged mice and mice 3, 7, or 10 days after LPS (n = 10–16 per condition). (G) The percentage of total CD4+ cells that were Foxp3+, determined 
in unchallenged mice or mice 3, 7, or 10 days after LPS (n = 10–16 per condition). Data are expressed as the mean ± SEM where applicable. P values were 
determined by 1-way ANOVA with Tukey’s multiple comparison test between conditions. **P < 0.01 ***P < 0.001, ****P < 0.0001.
log2 normalized intensity across samples (bright blue for lower expression levels, and bright red for high 
expression levels). Each column represents a transcript, and each row represents a replicate of  Treg RNA 
from a pooled set of  Tregs.
Unsupervised hierarchical clustering of  the 80 differentially expressed transcripts between resolv-
ing lung Tregs and control lung Tregs is shown in Figure 2E. The dendrogram identifies clustering 
across samples (top) or differentially expressed genes (DEGs; left). Twenty-three transcripts were 
upregulated, including Mmp12, C3ar1, and Lag3. Fifty-seven transcripts were downregulated, including 
Sik1 and Kdm6b. Interestingly, transcripts such as C3ar1, Kdm6b, Mmp12, and Sik1, which have little to 
no known role in Treg function, also showed significant differential expression between control lung 
Tregs compared with resolving lung Tregs (Figure 2F).
Transcripts previously demonstrated to be differentially regulated by Tregs during influenza-induced 
lung injury, such as Areg, Ctla4, and Itgae (CD103) (13), were found to be differentially expressed in our data 
Figure 2. The impact of both an inflammatory stimulus and location on the Treg transcriptome. Tregs were isolated from the lungs of unchallenged 
Foxp3EGFP mice or from the lungs and spleens from Foxp3EGFP mice 7 days after LPS (3 mg/kg i.t.) challenge. (A) Body weight relative to baseline mea-
sured daily before and after injury (n = 19 females; 39 males; 58 total). Data are expressed as the mean ± SEM. (B) Principal component analysis (PCA) of 
mRNA expression demonstrating the contribution of the top 3 principal components to the variance in the 3 Treg sets. Each symbol represents 1 sort of 
pooled Tregs from mice (15–27 mice/experiment); 3 arrays/set. (C) Venn diagram showing the overlap of significantly differentially expressed transcripts 
between sets (adjusted P < 0.05, fold change > 2). Area of the circles reflects the relative number of differentially expressed transcripts for each com-
parison. Numbers in parentheses indicate the total from the respective pairwise comparison. These transcripts are listed in Supplemental Tables 1–3. 
(D) Unsupervised hierarchical clustering with Euclidean distance metric of 1,599 differentially expressed transcripts identified in all 3 comparisons. The 
dendrogram identifies clustering across transcripts (top) or across experimental samples (right). The heatmap depicts the log2 normalized intensity, and 
each row represents Treg RNA from a pooled set of mice. As described in the Methods, transcripts between sorted Treg sets were identified by filtering 
at adjusted P < 0.05 and fold change > 2 (bright blue for lower expression levels and bright red for high expression levels). (E) Differentially expressed 
genes (DEGs) between resolving lung Tregs and unchallenged lung Tregs. Unsupervised hierarchical clustering of the unique 78 DEGs between lung 
Treg samples. The heatmap depicts the log2 normalized intensity across samples. Each column represents Treg RNA from pooled Tregs, and each row 
represents a DEG. The dendrogram identifies clustering across experimental samples (top) or DEGs (right). (F) Select list of transcripts with a >2-fold 
change between resolving lung Tregs and unchallenged lung Treg comparisons. (G) Select list of transcripts with a >2-fold change between resolving lung 
Tregs and resolving splenic Treg comparisons.
set of transcripts expressed by Tregs when resolving lung Tregs are compared with resolving splenic Tregs 
(Figure 2G). Interestingly, numerous chemokines, cytokines, and chemokine and cytokine receptors were 
differentially expressed, including Ccr2, Ccr5, Cxcl15, Cxcl16, Cxcr4, Cxcr5, IL10, Il1rl1, and Il18r1 (Figure 2G).
To identify biological pathways that may contribute to Treg-directed lung repair, we performed 
Gene Set Enrichment Analysis (GSEA) using gene sets derived from the public Gene Ontology (GO) 
database (http://www.geneontology.org/) and the rotation gene set tests (ROAST) statistical gene set 
test (26, 27). When the resolving lung Tregs are compared with the control lung Tregs, 13 significant 
gene sets were identified (Table 2).
Only 1 gene set was enriched and uniquely identified in comparisons of Tregs sorted from resolving 
lung Tregs and control lung Tregs. This gene set describes an oligosaccharide lipid intermediate biosynthetic 
process (GO0006490) that results in the formation of an oligosaccharide-lipid intermediate — for example, a 
molecule of dolichol-phosphate-mannose or dolichol-phosphate-glucose used in posttranslational modifica-
tion regulating protein folding, trafficking, and degradation (28). This pathway is important in glycosylation 
of receptors on other lymphocytes, and its role in regulation of receptors on Tregs has not been studied. One 
gene set was uniquely dampened in Tregs from resolving lung Tregs compared with control lung Tregs. This 
gene set described genes involved in the positive regulation of glucose metabolic process (GO0010907).
More than 800 gene sets were enriched or dampened in Tregs from resolving lungs compared 
with spleens. Selected interesting examples of  enriched gene sets (Table 3) include tolerance induction 
(GO0002507), regulation of  Treg differentiation (GO0045589), and lymphocyte migration (GO0073676). 
Dampened gene sets include regulation of  notch signaling pathway (GO0008593), T cell receptor signal-
ing pathway (GO0050852), and histone methylation (GO0032481). Taken together, these analyses have 
identified differentially regulated processes that suggest roles for Tregs in lung repair and that document 
a tissue-specific expression pattern for Tregs.
Treg CD103+ and IL18+ subsets increase in the lung during resolution of  LPS-induced ALI. These results 
from transcriptional profiling suggested that many potentially novel and exciting changes in Treg func-
tion are occurring, which led to studies immunophenotyping Tregs during resolution. First, lymphocyte 
kinetics in the lung and spleen during resolution were compared with uninjured lungs. The percentage 
of  CD4+ cells increased in the lung during resolution as a proportion of  total lymphocytes, whereas in 
the spleen, the percentage decreased (Figure 3A). The percentage of  Foxp3+ cells as a proportion of  
total CD4+ cells increased significantly in both organs (Figure 3B). The Foxp3+ fluorescence intensity 
increased significantly in both organs during ALI resolution in the Foxp3+ population (Figure 3C).
Second, transcriptome profiling showed that Itgae (CD103), Il1rl1 (ST2), and IL18r1 transcripts were 
upregulated in Tregs from resolving lungs compared with spleen. To investigate if  these transcriptional 
changes correlate with surface expression of  these gene products, Foxp3+ cells were examined by flow 
cytometry for expression of  CD103, IL-18 receptor 1 (IL-18R1), and IL1RL1 (ST2). The percentage 
of  Foxp3+ cells expressing CD103 or IL-18R increased at 7 days after LPS only in the lung and not in 
the spleen (Figure 3, D and E). The percentage change of  ST2+Foxp3+ cells between conditions also 
correlated with the array transcriptional changes. The percentage of  total Foxp3+ cells that express ST2+ 
actually decreased at day 7 after LPS in both the lung and spleen compared with uninjured Tregs in each 
tissue type (Figure 3F); however, the absolute number of  ST2+Foxp3+ cells increased, likely driven by the 
overall increase in Treg numbers. Most importantly, the total number of  lung Tregs expressing these 3 
receptors was significantly increased in resolving lungs compared with uninjured lungs (Figure 3, G–I).
Table 1. The number of up- or downregulated transcripts that were significantly differentially expressed between the 3 Treg sets
Comparison of Treg sets Number of transcripts
Upregulated Downregulated Total
Resolving lung Tregs vs. control lung Tregs 23 57 80 (5%)
Resolving lung Tregs vs. resolving splenic Tregs 514 519 1033 (65%)
Control lung Tregs vs. resolving splenic Tregs 464 584 1048 (65%)
The transcripts are upregulated or downregulated >2-fold and are filtered at an adjusted P < 0.05. Percentage (%) describes the percentage of the total 
number of transcripts (1,599).
Given the differential expression of  both the IL-18 receptor and IL-33 receptor transcripts in resolv-
ing lung Tregs, the expression kinetics of  these 2 cytokines was examined. Both IL-18 and IL-33 peaked 
in concentration in BAL supernatant fluid at day 1 after LPS injury (Supplemental Figure 2, A and B).
Expression of  chemokines and cytokines in BAL supernatants during LPS-induced ALI. Based on the dif-
ferential expression of  cytokine and chemokine receptors, we measured the changes in cytokines and 
chemokines present in the lungs before Tregs increase, testing the hypothesis that early immune signaling 
drives subsequent Treg recruitment and function during resolution of  ALI. The lungs of  WT mice given 
LPS were lavaged at day 1, 3, 7, or 10 after injury and compared with control, uninjured lung BAL fluid. 
The quantities of  23 cytokines and chemokines were determined (Table 4; graphical representation of  
several of  these cytokines and chemokines are plotted in Supplemental Figure 2, C–G). The gene pro-
filing data demonstrate increased expression of  mRNAs for CCR5, CCR2, and CXCR3. CCR5 is the 
receptor for CCL3 (MIP-1α), as well as for CCL4 (MIP-1β) and CCL5 (RANTES). The concentrations 
in the BAL supernatant of  these 3 chemokines are greatest early in LPS-induced injury, days 1–3 (Table 
4 and Supplemental Figure 2, C–E).
The chemokine receptor CCR2 mRNA is significantly increased in resolving lung Tregs when com-
pared with resolving spleen Tregs. Its respective chemokine, CCL2 (MCP-1), peaks in concentration at 
day 3 following LPS-induced lung injury (Table 4 and Supplemental Figure 2F).
Treg-depleted mice have increased immune cell numbers during ALI lung resolution. To determine the impact 
Treg depletion has on ALI resolution, we compared resolution in 2 transgenic strains, the Foxp3EGFP strain 
used for the transcriptomic analysis and the Foxp3DTR strain, which expresses both the human diphtheria 
toxin (DT) receptor (DTR) and GFP in the 3′ untranslated region of  the Foxp3 locus and allows for deple-
tion of  endogenous Tregs when DT is administered (29). By administering DT to the Foxp3DTR strain, we 
can examine the LPS-induced lung injury and recovery in the presence (Foxp3EGFP) or absence (Foxp3DTR) 
of  Tregs (Figure 4A). Mice depleted of  Tregs during ALI have similar weight loss and recovery compared 
with control at this dose of  LPS (Figure 4B); however, Treg-depleted mice have increased cellularity, as 
demonstrated both by histopathology of  lung tissue at 7 days after LPS (Figure 4C) and total number of  
cells obtained from enzymatic single cell lung suspensions (Figure 4D). Treg depletion was confirmed by 
decreased CD4+Foxp3+ lymphocytes in the Treg-depleted mice (Figure 4E). Furthermore, Treg-depleted 
mice had elevated numbers of  neutrophils, alveolar macrophages, and interstitial macrophages, as deter-
mined by total numbers in single cell suspensions using a published flow cytometric panel and gating 
Table 2. Comparison: Resolving lung Tregs vs. control lung Tregs
Upregulated in resolving lung Tregs Downregulated in resolving lung Tregs
Ontology ID Functional term Number of genes Ontology ID Functional term Number of genes
GO0046500 S-adenosylmethionine 
metabolic process
10 GO0007176 Regulation of epidermal growth  
factor-activated receptor activity
14
GO0006490 Oligosaccharide lipid 
intermediate biosynthetic process
11 GO0007175 Negative regulation of epidermal growth 
factor activated receptor activity
10
GO0006490 Vesicle transport along 
microtubule
31 GO0061099 Negative regulation of protein tyrosine 
kinase activity
17
GO0009712 Catechol-containing compound  
metabolic process
19
GO0010907 Positive regulation of glucose  
metabolic process
24
GO2000272 Negative regulation of receptor activity 17
GO0006584 Negative regulation of epidermal growth 
factor receptor signaling pathway
18
GO0006584 Catecholamine metabolic process 19
GO0031958 Corticosteroid receptor signaling pathway 13
GO1901185 Negative regulation of ERBB  
signaling pathway
19
Gene Set Enrichment Analysis identified Gene Ontology Biological Pathways showing highly significant enrichment between Treg sets. All significant 
gene sets that were differentially regulated between resolving lung Tregs and control lung Tregs comparisons are listed. The 2 gene sets unique only in 
this comparison are identified in italics. Sets have a FDR < 0.1.
approach (Figure 4, F–J) (30). We also detected differences in lymphocyte subsets numbers in the single 
cell suspensions between the 2 conditions. The numbers of  CD3+, CD4+, and CD8+ lymphocytes were 
increased, and γδ+ T cell and CD19+ lymphocytes were decreased in Treg-depleted mice (Figure 4, K–Q; 
lymphocyte gating scheme described in Supplemental Figure 3).
Tregs from LPS-treated lungs increase expression of  Mmp12. Mmp12 was one of  the most highly expressed 
DEGs in Tregs during ALI resolution compared with either of  the other conditions (Figure 2, F and G). 
To confirm Treg expression of  Mmp12 transcripts, we sorted Tregs (GFP+ lymphocytes) from the lungs of  
Foxp3EGFP mice that were either uninjured or 7 days after LPS injury, when the ALI is resolving, to obtain 
highly purified Foxp3+ cells. Tregs from resolving ALI expressed many fold more Mmp12 transcripts 
compared with uninjured Tregs (Figure 5A).
Treg-depleted mice repleted with Tregs lacking MMP12 expression have more lung neutrophils during resolution 
of  LPS-induced ALI. To begin to determine the role of  MMP12 expressed by Tregs in mediating inflamma-
tion resolution, we performed adoptive transfer experiments of  either Foxp3EGFP (Mmp12+/+) or Mmp12–/– 
Tregs into Treg-depleted (Foxp3DTR) mice (Figure 5B) (16). The data show that, by day 7 after injury, mice 
exposed to LPS and repleted with either Mmp12+/+ or Mmp12–/– Tregs have begun to recover from their 
weight loss due to the injury, which nadirs at day 4 after LPS (Figure 5C). Total BAL cell numbers, BAL 
total protein concentration, and total lung cell count in the enzymatically digested single cell suspensions 
at day 7 after injury remain similar between Mmp12+/+ or Mmp12–/– Treg-repleted mice (Figure 5, D–F). 
The number of  Foxp3+ cells in single cell suspensions generated from lung digests following lung lavage 
was not significantly different between the 2 conditions (Figure 5G). Moreover, we did not detect any 
differences in lymphocyte subsets in the single cell suspensions between the 2 conditions (CD3+, CD4+, 
CD8+, γδ+, NK, and NK T cells; Supplemental Figure 4). Further immunophenotyping of  macrophage, 
monocyte, and neutrophil populations (Figure 5, H–L) using a published flow cytometric panel and 
gating approach (30) demonstrated that Foxp3DTR mice depleted of  endogenous Tregs and then repleted 
with Mmp12–/– Tregs at the time of  injury had greater numbers of  neutrophils and a trend for increased 
interstitial macrophages compared with Foxp3DTR mice repleted with Mmp12+/+ Tregs (Figure 5, I and J). 
Table 3. Comparison: Resolving lung Tregs vs. resolving splenic Tregs
Upregulated in resolving Lung Tregs Downregulated in resolving lung Tregs
Ontology ID Functional term Number of genes Ontology ID Functional term Number of genes
GO0002507 Tolerance induction 23 GO0000959 Mitochondrial RNA metabolic process 28
GO0002028 Regulation of sodium ion 
transport
44 GO0030488 tRNA methylation 20
GO0045589 Regulation of regulatory  
T cell differentiation
19 GO0031063 Regulation of histone deacetylation 22
GO0002825 Regulation of T-helper 1 type 
immune response
20 GO0008593 Regulation of Notch  
signaling pathway
42
GO0010574 Regulation of vascular 
endothelial growth factor 
production
20 GO0038202 TORC1 signaling 20
GO0072676 Lymphocyte migration 57 GO0050852 T cell receptor signaling pathway 65
GO0070849 Response to epidermal growth 
factor
24 GO0001912 Positive regulation of leukocyte 
mediated cytotoxicity
34
GO1902622 Regulation of neutrophil 
migration
28 GO0016571 Histone methylation 108
GO0050715 Positive regulation of cytokine 
secretion
74 GO0032481 Positive regulation of type I interferon 
production
37




GO0071277 Cellular response  
to calcium ion
29
Gene Set Enrichment Analysis identified Gene Ontology Biological Pathways showing highly significant enrichment between Treg sets. Selected 
gene sets of interest that were differentially regulated between resolving lung Tregs and resolving splenic Tregs comparisons are listed. Sets are 
listed only if FDR < 0.1.
These results suggest that Treg-expressed MMP12 plays a role in Treg-promoted resolution of  the inflam-
matory process but is not required for Tregs to traffic to the lung or survive there.
Treg-depleted mice repleted with Tregs lacking SIK1 expression have more Tregs in the lung and an increased 
Treg expression of  CD103 during ALI resolution. Salt inducible kinase 1 (Sik1) was one of  the significantly 
downregulated DEGs in resolving lung Tregs during ALI resolution compared with control lung Tregs 
(Figure 2, F and G). Sik1 encodes a serine/threonine protein kinase that is a member of  the adenosine 
monophosphate-activated kinase (AMPK) subfamily of  kinases. It also contains an ubiquitin-associated 
(UBA) domain. It is expressed by macrophages and contributes to proinflammatory signaling pathways 
initiated through TLRs or IL-1 (31, 32). Recently, members of  this salt-inducible kinase family have been 
Figure 3. Protein expression of receptors and other surface molecules on Foxp3+ Tregs in the lung and spleen and their numbers in lung during ALI 
resolution compared with unchallenged mice. Foxp3EGFP mice were challenged with LPS (3 mg/kg i.t.) and compared with unchallenged Foxp3EGFP mice 
(labeled as “LPS–” mice in figures). (A) Percentages of CD4+ cells were compared with the total number of lymphocytes in the lymphocyte gate deter-
mined by flow cytometry in lung or spleen single cell suspensions of unchallenged (control) mice or at 7 days after LPS (n = 6–8 per condition). (B) The 
percentage of total CD4+ cells that expressed Foxp3 was determined (n = 6–14 per set). (C) Median fluorescence intensity (MFI) of GFP expression driven 
by the endogenous Foxp3 promoter was determined in the lung and spleen in unchallenged mice or at 7 days after LPS (n = 6–8 per condition). (D–F) 
Percentages of CD103+Foxp3+ cells (D), IL18R+Foxp3+ cells (E), and ST2+Foxp3+ cells (F) as a percentage of total Foxp3+ cells (n = 6–14 per condition). (G–I) 
Numbers of CD103+Foxp3+ cells (G), IL18R+Foxp3+ cells (H), and ST2+Foxp3+ cells (I) determined in the lung between conditions (n = 6–8 per condition). 
Data are expressed as the mean ± SEM. Mann Whitney rank sum test determined P values.
demonstrated to play a role in Treg energy homeostasis as one of  several important effectors of  liver 
kinase B1 (LKB1) signaling (33).
To examine the role of  SIK1 expressed by Tregs in mediating inflammation resolution, we per-
formed adoptive transfer experiments of  either Foxp3EGFP (Sik1+/+) or Sik1–/– Tregs into Treg-depleted 
(Foxp3DTR) mice (16). The data demonstrate that, by day 7 after injury, mice repleted with either 
Sik1+/+ or Sik1–/– Tregs have similar weight recovery and total lung cell numbers (Figure 6, A and B). 
Interestingly, Treg-depleted mice repleted with Sik1–/– Tregs have increased Treg numbers in the lung 
at 7 days after injury and an increased percentage and number of  Tregs expressing CD103 during 
lung resolution, compared with mice repleted with Sik1+/+ Tregs (Figure 6, C–G). Also, Treg-depleted 
Table 4. Cytokines measured in BAL fluid in unchallenged (control) mice or at day 1, 3, 7, or 10 after LPS in WT mice 
Days after LPS
Analyte (pg/mL) Control (n = 8) Day 1 (n = 11) Day 3 (n = 13) Day 7 (n = 13) Day 10 (n = 11)
Eotaxin <LLOQ 574.5 ± 55.8 459.3 ± 29.3 <LLOQ <LLOQ
G-CSF 4.3 ± 0.8 (n = 5) 
<LLOQ (n = 3)
2705601 ± 1940.3 19278.5 ± 2917 87.7 ± 27.1 22.6 ± 12.3 (n = 7) 
<LLOQ (n = 4)
GM-CSF 28.41 (n =1) 
<LLOQ (n = 7)
125.5 ± 33.2 69.3 ± 8.5 (n = 12) 
<LLOQ (n = 1)
<LLOQ <LLOQ
IFN-γ 2.1 ± 1.8 (n = 2) 
<LLOQ (n = 6)
12.2 ± 1.6 (n = 8) 
<LLOQ (n = 3)
24.7 ± 3.9 (n = 12) 
<LLOQ (n = 1)
<LLOQ <LLOQ
IL-10 1.1 ± 0.8 (n = 2) 
<LLOQ (n = 6)
30.3 ± 7.0 25.4 ± 0.9 0.8 ± 0.1 (n = 2) 
<LLOQ (n = 9)
0.3 (n = 1) 
<LLOQ (n = 10)
IL-12 (p40) 21.4 ± 4.3 155.0 ± 17.5 19655 ± 226.0 114.6 ± 13.0 92.1 ± 8.4
IL-12 (p70) 9.0 ± 4.0 (n = 3) 
<LLOQ (n = 5)
80.6 ± 13.5 239.6 ± 29.1 <LLOQ <LLOQ
IL-13 26.3 ± 9.8 (n = 3) 
<LLOQ (n = 5)
111.6 ± 9.3 115.5 ± 4.4 15.5 ± 2.4 (n = 7) 
<LLOQ (n = 6)
9.2 ± 4.7 (n = 4) 
<LLOQ (n = 7)
IL-17A 3.16 (n = 1) 
<LLOQ (n = 7)
7.1 ± 0.9 58.7 ± 7.2 1.19 ± 0 (n = 2) 
<LLOQ (n = 11)
<LLOQ
IL-1a 1.22 (n = 1) 
<LLOQ (n = 7)
6.5 ± 0.5 16.4 ± 1.4 <LLOQ 1.97 (n = 1) 
<LLOQ (n = 10)
IL-1β 8.0 ± 5.5 (n = 3) 
<LLOQ (n = 5)
107 ± 9.9 146 ± 11.2 5.36 ± 3.0 (n = 2) 
<LLOQ (n = 11)
<LLOQ
IL-2 <LLOQ <LLOQ <LLOQ <LLOQ <LLOQ
IL-3 0.11 (n = 1) 
<LLOQ (n = 7)
2.5 ± 0.3 (n = 10) 
<LLOQ (n = 1)
2.2 ± 0.3 (n = 12) 
<LLOQ (n = 1)
<LLOQ <LLOQ
IL-4 <LLOQ 5.6 ± 0.7 (n = 10) 
<LLOQ (n = 1)
5.1 ± 0.4 (n = 10) 
<LLOQ (n = 3)
<LLOQ <LLOQ
IL-5 <LLOQ 20.6 ± 3.1 12.6 ± 1.2 2.5 (n = 1) 
<LLOQ (n = 12)
<LLOQ
IL-6 <LLOQ 854.4 ± 144.6 2142.3 ± 228.6 10.7 ± 8.3 (n = 3) 
<LLOQ (n = 10)
4.0 ± 2.7 (n = 2) 
<LLOQ (n = 9)
IL-9 78.4 ± 3.1 (n = 3) 
<LLOQ (n = 5)
85.8 ± 4.4 (n = 8) 
<LLOQ (n = 3)
<LLOQ 35.8 ± 7.0 (n = 3) 
<LLOQ (n = 10)
28.4 ± 4.3 (n = 6) 
<LLOQ (n = 5)
KC 5.0 ± 0.8 1389.4 ± 592.7 413.1 ± 62.1 19.5 ± 2.5 4.9 ± 0.8
MCP-1 21.7 ± 8.6 (n = 4) 
<LLOQ (n = 4)
747.9 ± 153.8 2517.2 ± 593.3 24.2 ± 4.4 (n = 12) 
<LLOQ (n = 1)
10.5 ± 3.0 (n = 5) 
<LLOQ (n = 6)
MIP-1α <LLOQ 1353.8 ± 444.1 799.4 ± 83.4 5.0 ± 1.2 4.1 ± 2.0 (n = 3) 
<LLOQ (n = 8)
MIP-1β 0.986 (n = 1) 
<LLOQ (n = 7)
837.1 ± 481.4 957.4 ± 129.6 7.0 ± 3.3 (n = 6) 
<LLOQ (n = 7)
3.2 (n = 1) 
<LLOQ (n = 10)
RANTES 1.17 (n = 1) 
<LLOQ (n = 7)
772.0 ± 100.6 829.0 ± 83.5 6.4 ± 1.4 2.4 ± 1.3 (n = 4) 
<LLOQ (n = 7)
TNF-α 1.99 (n = 1) 
<LLOQ (n = 7)
1192.7 ± 287.2 251.3 ± 50.3 <LLOQ <LLOQ
Values are mean ± SEM. Samples with values below the lower limit of quantitation (LLOQ) for the assay are noted in the table and not included in the 
calculation of mean and SEM. The number of samples in each condition (n) is shown in the column subheadings unless otherwise indicated in the 
individual cells. Samples are combined from 2 independent experiments.
mice repleted with Sik1–/– Tregs have decreased Foxp3+ expression, as measured by median fluores-
cence intensity (MFI) in Foxp3+ cells (Figure 6D). Furthermore, the percentage of  Foxp3+ cells that 
coexpressed IL-18R was increased in Foxp3DTR mice repleted with Sik1–/– Tregs compared with Sik1+/+ 
Tregs (Figure 6H). Studies quantifying myeloid cell subsets demonstrated that Foxp3DTR mice depleted 
of  endogenous Tregs and then repleted with Sik1–/– Tregs at the time of  injury had fewer Ly6C– mono-
cyte/macrophages compared with Foxp3DTR mice repleted with Sik1+/+ Tregs (Figure 6, I–M). We did 
Figure 4. Treg-depleted mice have increased immune cell numbers during resolution of acute lung injury. (A) Foxp3EGFP or Foxp3DTR mice (n = 9–15 per 
group, combined from 2 separate experiments) were challenged with intraperitoneal diphtheria toxin (DT; 50 μg/kg or 10 μg/kg) administered at days 
–2, –1, 1, 3, and 5 along with intratracheal LPS was administered at day 0. Mice were examined at 7 days after LPS for immune cell populations. (B) Body 
weight relative to baseline determined after injury. (C) Representative H&E lung sections reveal increased cellularity 7 days after LPS and DT in Treg-de-
pleted mice. Gray scale bar: 1 mM. Black scale bar: 500 μM. Maroon scale bar: 250 μM. (D) Total lung cell count from single cell lung suspension obtained 
at day 7 after DT and LPS treatment demonstrated increase cellularity in Treg-depleted mice. (E) Total CD4+Foxp3+ lymphocyte numbers determined and 
which confirm Treg depletion. (F–J) Changes in myeloid cell subsets as total numbers in single cell suspensions determined using a published flow cyto-
metric panel and gating approach (30). Treg-depleted mice had significant increases in alveolar macrophages, neutrophils, and interstitial macrophages. 
(K–Q) Changes in lymphocyte subsets as a total numbers in single cell suspensions determined and demonstrated increased numbers of CD3+, CD4+, and 
CD8+, γδ+, NK, and NKT lymphocytes. (N–O) Numbers of CD19+ and γδ+ lymphocytes were also found at lower numbers in Treg-depleted mice. Data are 
expressed as the mean ± SEM. P values calculated by Mann Whitney rank sum test. *P < 0.05, **P < 0.01 ***P < 0.001, ****P < 0.0001.
not detect any differences in lymphocyte subsets between the 2 conditions (CD3+, CD4+, CD8+, γδ+, 
NK, and NK T cell numbers; Supplemental Figure 5).
Discussion
In this report, we explored the global transcriptional changes occurring in Tregs during resolution of  lung 
injury. We compared uninjured lung Treg expression profiles with lung Tregs isolated 7 days after injury, as 
earlier studies demonstrated that Foxp3+ Treg numbers peak at this time point and directly enhance alveolar 
Figure 5. Treg-depleted mice repleted with Tregs lacking MMP12 expression have more neutrophils during lung resolution. (A) Mmp12 transcript concentra-
tions determined by digital droplet RT-PCR analysis. CD4+GFP+ cells (Tregs) sorted from the lungs of Foxp3EGFP mice either from control lungs or lungs resolving 
from ALI (n = 2 per group, representative of 3 separate experiments). P value by 2-tailed Student t test. (B–L) Foxp3DTR (DTR) mice were given diphtheria toxin 
(DT) to deplete endogenous Tregs as previously described (16), followed by LPS. One hour after LPS challenge, the DTR mice received 1 × 106 CD4+CD25+ cells 
(Tregs) from either Foxp3EGFP or Mmp12–/– mice. n = 12–14 per group, combined from 2 separate experiments. Samples are combined from 2 independent experi-
ments (B). Adoptive transfer of Mmp12–/– Tregs have similar weight recovery (C), BAL cell counts (D), and BAL total protein (E) after LPS-induced ALI compared 
with Foxp3EGFP Tregs (Mmp12+/+) 7 days after LPS administration. Total lung cell count and the number of Tregs between the adoptive transfer conditions did 
not differ (F and G). Changes in myeloid cell subsets as total numbers in single cell suspensions determined using a published flow cytometric panel and gating 
approach (30) (H–L). Foxp3DTR mice depleted of endogenous Tregs and then repleted with Mmp12–/– Tregs at the time of injury had greater neutrophil cell num-
bers and a trend for increased interstitial macrophages numbers compared with Foxp3DTR mice repleted with Mmp12+/+ Tregs 7 days after LPS administration 
(I–J). Data are expressed as the mean ± SEM. P values calculated by Mann Whitney rank sum test.
epithelial proliferation in 2 mouse models of  lung regeneration (11). Tregs increased 3.7-fold in the Foxp3EGFP 
mice, which is a similar change compared with other reports (11). Our studies demonstrate how Tregs reg-
ulate their transcriptional profile during ALI and that Tregs display heterogeneity in their responses, likely 
reflecting variation in the microenvironment. This heterogeneity may suggest functional variations within 
the Treg population important for spatial variation in the process of  resolution within the distal lung. Fur-
thermore, there are tissue-specific transcriptional differences during injury, which also show heterogeneity.
Tregs function in 2 major ways; they serve to modulate immunosuppression, and they participate in the 
resolution and repair of  damaged tissue. Some of  the immunosuppressive effects occur through Treg-expressed 
molecules, such as CD39, CD73, CTLA-4, galectin, glucocorticoid-induced TNFR-related protein (GITR), 
granzyme-B, IL-10, IL-35, lymphocyte-activation gene 3 (LAG-3), neuropilin, perforin, and TGF-β (34–36). 
Figure 6. Treg-depleted mice repleted with Tregs lacking SIK1 expression have more Tregs and increased Treg CD103 expression during lung 
resolution. Foxp3DTR (DTR) mice were given diphtheria toxin (DT) to deplete endogenous Tregs as previously described (16), followed by LPS. One 
hour after LPS challenge, the DTR mice received 1 × 106 CD4+CD25+ cells (Tregs) from either Foxp3EGFP or Sik1–/– mice. Samples are combined from 4 
independent experiments (n = 22–35 per group). (A) Weight recovery after LPS-induced ALI is similar after adoptive transfer of Sik1–/– Tregs com-
pared with Foxp3EGFP Tregs (Sik1+/+) 7 days after LPS administration. (B) Total lung cell count did not differ between the adoptive transfer conditions. 
(C–E) Foxp3DTR mice depleted of endogenous Tregs and then repleted with Sik1–/– Tregs at the time of injury had greater numbers of Foxp3+ cells 
(C), decreased Foxp3+ expression as measured by median fluorescence intensity (MFI) in Foxp3+ cells (D), and a greater percentage of Foxp3+ cells 
coexpressing CD103 (E). (F–G) The increased percentage of Foxp3+ cells expressing CD103+ correlated with a greater number of Foxp3+CD103+ Tregs 
(F) and a higher expression of CD103 in Tregs as measured by MFI (G). (H) The percentage of Foxp3+ cell that coexpressed IL18R was also increased in 
Foxp3DTR mice repleted with Sik1–/– Tregs compared with Sik1+/+ Tregs. (I–M) Changes in myeloid cell subsets as total numbers in single cell suspen-
sions determined using a published flow cytometric panel and gating approach (30). Foxp3DTR mice depleted of endogenous Tregs and then repleted 
with Sik1–/– Tregs at the time of injury had less Ly6C– monocyte/macrophage numbers compared with Foxp3DTR mice repleted with Sik1+/+ Tregs. Data 
are expressed as the mean ± SEM. P values calculated by Mann Whitney rank sum test.
Effector CD44hi Tregs have been previously demonstrated to upregulate many of  the above factors (35), 
and Cd44 mRNA expression is 2.4-fold greater in lung Tregs compared with spleen Tregs during LPS injury 
in our studies (Supplemental Table 2). However, many of  these molecules are not changed in Tregs from 
injured compared with uninjured lungs at 7 days, suggesting that, at this time point of  ALI resolution, Tregs 
are not transcriptionally regulating these factors, such as Entpd1 (CD39), Gzmb, and Il10.
Beyond their immunosuppressive roles, Tregs function in tissue repair through the expression of  
growth factors, including AREG and KGF (13, 14, 16). Our data demonstrate that, during the reparative 
process, Tregs from resolving lungs increase their expression of  Areg compared with unchallenged lung 
Tregs and with resolving splenic Tregs.
Our transcriptome data place resolving lung Tregs in more activated states compared with splen-
ic Tregs obtained from the same mice. A recent study using single cell RNA sequencing (scRNAseq) 
demonstrated heterogeneity in unstimulated Tregs from murine spleens and suggested that Treg subpop-
ulations can be defined based on temporal changes in activation state (37). Our data show that resolving 
lung Tregs express increased Nr4a1 mRNA, which is an orphan nuclear receptor that increases early in 
TCR-mediated activation (37). Moreover, increased expression of  Ccr2, Cxcr3, and Itgae are also associ-
ated with strongly activated Treg phenotypes (37). Il18r1 and Il1rl1, the receptors for the cytokines IL-18 
and IL-33, are transcriptionally upregulated in lung Tregs compared with splenic Tregs from mice with 
resolving ALI (Figure 2G). The increases in surface expression of  CD103 (Itgae) and IL-18R in lung Tregs 
during ALI resolution determined by immunophenotyping show that these genes are translated and may 
be functionally important (Figure 3, D–E). While the percentage of  Tregs that express CD103 increases 
approximately 25%, this correlates with a 3.9-fold increase in the number of  lung CD103+ Tregs. Our 
prior work demonstrates that blocking CD103 interaction with its receptor, E-cadherin, results in fewer 
Tregs retained in the lung after LPS-induced ALI and abrogates Treg-promoted epithelial repair (11). 
The increased size of  the Treg population that expresses either CD103, ST2, or IL-18R suggests that sub-
populations develop, which are likely to have functional importance during resolution of  ALI (37, 38).
Tregs differentially express several chemokine receptors during ALI resolution, including upregu-
lation of  CCR2, CCR5, and CXCR4 and downregulation of  CXCR5 (Figure 2G). The CCR2 ligand 
CCL2 (MCP-1) peaks in concentration within the alveolar space at day 3 (Table 4 and Supplemental 
Figure 2F). The expression of  3 CCR5 receptor ligands, — CCL3 (macrophage inflammatory pro-
tein-1a, MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES) — peaks from days 1–3 (Table 4 and Sup-
plemental Figure 2, C–E). The ligand for the CXCR4 receptor is CXCL12 (stromal cell–derived factor 
1; SDF-1). CXCL12 has been shown to be important for repair of  the alveolar epithelium after ALI 
(39). How these chemokines modulate Treg recruitment and retention, as well as the Treg-mediated 
repair of  the alveolar septa, is left to be determined.
Interestingly, differential expression of  other gene transcripts, including Sgk1 and Mmp12, were found 
in resolving lung Tregs compared with resolving splenic Tregs (Figure 2G). Prior work has demonstrated 
that the serum/glucocorticoid-regulated kinase, SGK1, mediates increased IFN-γ expression by Tregs 
and results in defects in Treg function (19). Sgk1 expression increases 2.5-fold in resolving lung Tregs 
compared with resolving splenic Tregs (Figure 2G and Supplemental Table 2). Based on prior work, this 
increase may suggest a shift toward a Th1-proinflammatory Treg phenotype, as marked by an increase 
in CXCR3 (19), which is also increased in resolving lung Tregs compared with resolving splenic Tregs 
(Supplemental Table 2). These data suggest that Tregs show heterogeneity at this time point. Our studies 
suggest that understanding Treg plasticity during ALI resolution will be fruitful.
To our knowledge, expression of  metalloproteinases (MMPs) such as MMP12 by Tregs has not been 
identified in lung Tregs; however, the role for MMPs in tissue repair and ALI has been an area of  much 
investigation (40). Mmp12 expression increases 23-fold in resolving lung Tregs compared with control 
lung Tregs and 37-fold in resolving lung Tregs compared with resolving splenic Tregs (Figure 2, F and 
G, and Supplemental Tables 1 and 2). To further pursue the functionalities of  Treg-specific expression 
of  MMP12 in ALI resolution, we carried out adoptive transfer of  Mmp12+/+ (Foxp3EGFP) and Mmp12–/– 
Tregs. Our data demonstrate that repleting with Mmp12–/– Tregs results in more neutrophils in the lung 
after LPS-induced injury than repleting with Mmp12+/+ Tregs (Figure 5I), suggesting that Treg-generated 
MMP12 is important in the resolution of  lung injury. The potential role of  Treg-expressed MMPs in 
regulating the processing of  chemotactic signals or turnover of  the extracellular matrix to promote ALI 
resolution is unknown. Interestingly, MMP12 plays a role in regulating antiviral immunity by binding to 
the promoter of  the transcription factor NFKBIA, which mediates IFN-α secretion, along with degrading 
extracellular IFN-α and resolving inflammation (41, 42). Other work has demonstrated that MMP12 
cleaves IFN-γ at the c-terminus, which can abrogate IFN-γ signaling (43). Our results propose multiple 
potential functions and testable hypotheses for Treg-expressed MMP12 in lung repair.
The molecular network that directs Treg functions requires epigenetic programming (44); for exam-
ple, inhibitors of  DNA methyltransferases accelerate resolution of  lung inflammation (45). Our studies 
identified 3 genes, Uhrf1, Kdm6b, and Sik1, which have well-recognized roles in epigenetic modifications. 
Uhrf1 is an ubiquitin ligase (46), and its expression increased 4.31-fold in lung Tregs compared with 
splenic Tregs during LPS injury in our studies (Figure 2G and Supplemental Table 2). UHRF1 recruits 
the methyltransferase, DNMT1, to regulate gene expression by modifying chromatin structure (46). Mice 
with CD4+ T cell–specific deficiency in Uhrf1 had defective proliferation and functional maturation of  
colonic Tregs (47). Kdm6b (also called Jmjd3) codes for another epigenetic modifying factor, a lysine-spe-
cific demethylase, that was downregulated 2.89-fold in Tregs after LPS injury (Supplemental Table 1). 
Previous studies demonstrate that KDM6B is an epigenetic factor in T cell differentiation (48, 49). Abla-
tion of  Kdm6b affects CD4+ T cell differentiation, and in vitro induction of  Tregs was markedly reduced 
in Kdm6b-deficient T cells compared with WT T lymphocytes (48). Sik1 expression decreased 2.88-fold 
in resolving lung Tregs compared with control lung Tregs (Figure 2F and Supplemental Table 1). SIK1 is 
a Ser/Thr kinase that phosphorylates and regulates class II histone deacetylase (HDAC) kinases, among 
other targets (50). Recently, SIK kinases have been demonstrated to play a role in Treg energy homeo-
stasis as one of  several important effectors of  LKB1 signaling (33). The role of  Treg-expressed SIK1 in 
lung resolution has not been reported, and our data demonstrate that SIK1 functions in Tregs to regulate 
CD103 and IL-18 receptor expression, which may help function in retaining Tregs to sites of  inflam-
mation and directing Treg immune and metabolic function (33). Thus, our gene expression data sup-
port a role for the epigenetic regulation of  Treg responses in ALI resolution. Further work investigating 
epigenetics through multi-omics approaches identifying DNA methylation sites and utilizing chromatin 
accessibility assays will help further define tissue-specific Treg responses (51).
One limitation of  this study is that the adoptive transfer experiments do not fully reconstitute Tregs 
back to WT numbers, which we have previously reported (11). This may contribute to the modest dif-
ferences seen in the adoptive transfer experiments and may limit detection of  other differences. Future 
efforts utilizing conditional and cell-specific KOs will more definitively answer these questions, as these 
tools become available.
Although the Tregs were sorted to high-percent purity, the array data suggest some impurity from 
sources other than Tregs. For example, surfactant protein transcripts are differentially expressed and 
upregulated in lung Tregs vs. splenic Tregs. Immunoglobulin transcripts and hemoglobin α and β tran-
scripts are enriched in splenic Tregs. These findings may be due to extracellular vesicles, which can pack-
age DNA and mRNAs from other cell types within these organs (52). These vesicles potentially adhere to 
the Tregs and may, thus, be sorted with them.
Our study did not differentiate the percentage of  thymically derived vs. peripherally derived, induc-
ible Foxp3+ Tregs. The distinction and functions of  thymically derived Foxp3+ Tregs (tTregs) and 
CD4+-derived, peripherally induced Foxp3+ Tregs (pTregs) are an active area of  investigation (53), and 
distinguishing between these 2 populations could not be incorporated into our study design. Moreover, 
the proportion of  lung Tregs that are resident lung Tregs and undergo proliferation during ALI resolution 
vs. the proportion that are circulating and recruited are important questions that remain to be answered. 
Interestingly, in the 2 resolving Treg populations, the transcript for Mki67 is upregulated 28-fold in resolv-
ing lung Tregs compared with resolving splenic Tregs, suggesting — along with previous work — that 
Treg proliferation is an important component of  the reparative response (12).
In summary, resolution of  lung injury is an active process, and understanding the role of  the cell types 
and their interactions in the reparative process is critical for the intelligent development of  therapeutic 
interventions. Our studies identify potential mechanisms of  Treg function, both in suppressing the inflam-
matory response and their recently described tissue-reparative functions. These studies provide insight into 
transcriptional differences by which Tregs may direct their suppressive or tissue-reparative effects during 
resolution of  ALI and further support the emerging role of  Tregs in resolution and repair of  lung injury. 
Understanding prorepair and immune regulatory functions of  Tregs and the translation of  this work to 
human diseases such as ARDS may inform studies of  Tregs as a cell-based therapy (51, 54, 55).
Methods
Mice. Foxp3DTR, Foxp3EGFP, and Mmp12–/– mice were obtained from the Jackson Laboratory, and colo-
nies of  these mice were maintained at the UNC (22, 29, 56). C57BL/6N-Sik1tm1.1(KOMP)Vlcg (RRID:MMR-
RC_049654-UCD) mice were created and archived by Charles River Laboratory from ES cell clone 
14108A-D8, generated by Regeneron Pharmaceuticals Inc. and provided to the KOMP Repository 
(www.komp.org) as part of  the KOMP2 Project by Charles River Laboratory (57). Cryopreserved sperm 
were obtained from KOMP at the UCD (Davis, California, USA). Sperm cryorecovery using C57BL/6J 
female oocyte donors was performed by the Mutant Mouse Resource and Research Center at UNC 
through the UNC Cryogenics Core. Mice were bred and housed in ventilated cages within a specific 
pathogen-free facility at the UNC at Chapel Hill.
Preparation of  mice for LPS administration. Eight- to 12-week-old male and female mice were anes-
thetized with tribromoethanol before tracheal intubation and administration of  lipopolysaccharide, 
E. coli LPS O55:B5 (3 mg/kg) (MilliporeSigma), as previously described (11, 12, 16). Mice were
studied after 1, 3, 7, or 10 days and were compared with unchallenged age- and sex-matched mice
of  the same genotype. At endpoints, mice were euthanized by isoflurane overdose and exsanguina-
ted from their inferior vena cava, as previously described (16). Lungs and spleens were removed,
and single cell suspensions were generated for flow cytometry analysis or cell sorting, as previously
described (11, 16).
DT administration. DT (List Biologicals Laboratories) was suspended in PBS. Stock solutions were 
thawed once, and mice were injected i.p. with DT as previously described (11, 29).
Isolation of  Foxp3EGFP and Mmp12–/– CD4+CD25+ Tregs and adoptive transfer. Spleens from male and female 
Foxp3EGFP, Mmp12–/–, or Sik1–/– mice were removed, and single cell suspensions were prepared. Tregs were 
then isolated using the EasySep Mouse CD4+CD25+ Regulatory T Cell Isolation Kit II per the vendor’s 
protocol (Stemcell Technologies) (16). Adoptive transfer of  Tregs (1 × 106) was performed following LPS 
administration by retro-orbital injection into Treg-depleted Foxp3DTR mice as previously reported (16).
Quantifying cytokine and chemokine patterns of  alveolar injury in BAL fluid. BAL was performed in 
unchallenged lungs or at day 1, 3, 7, or 10 after LPS-induced lung injury, as previously described (11, 
12). The BAL fluid was centrifuged at 400 g to sediment cells, and the supernatants were centrifuged 
at 1,300 g to remove cell debris and other particulates. The Bio-Plex MAGPIX platform (Bio-Rad) 
was used to measure the levels of  23 cytokines/chemokines in the BAL fluid supernatants per the 
manufacturer’s protocol.
Preparation of  lung single cell suspensions for flow cytometry analysis and cell sorting. Lungs were digested 
by i.t. instillation via a 20-gauge catheter of  1 ml of  5 mg/ml collagenase I (Worthington Biochemical 
Corp.) and 0.25 mg/mL DNase I (MilliporeSigma) prepared in RPMI media (Invitrogen) prior to instill-
ing 0.5 ml of  1% (wt/vol) low-melting agarose (Invitrogen) similar to previous protocols (16). Lungs were 
incubated at 37°C for 30 minutes and then minced and triturated through an 18-gauge needle. Cell sus-
pensions were then filtered through a 100-μM filter prior to RBC lysis and stained as previously described 
(11). For cell sorting experiments, single cell lung digests from 15–27 Foxp3EGFP mice were pooled prior to 
sorting to obtain sufficient Treg numbers and RNA for analysis. For multicolor flow cytometry analysis 
of  lung cells, studies were performed using digests from individual mice.
Multicolor flow cytometry for cell analysis. Single cell suspensions were suspended in buffer (PBS with 
1.6 % BSA, MilliporeSigma), and the total cell count was determined by hemocytometer. Cells (1.5 × 
106 cells) first underwent Fc receptor blockade using rat anti–mouse FcγRIII/II receptor (CD16/32; BD 
Biosciences). After blocking for 5 minutes on ice, cells were surface stained using antibodies obtained 
from BioLegend, eBioscience, or BD Biosciences (Supplemental Table 4). The cells underwent fixation 
and permeabilization with the Foxp3/Transcription Factor Staining Buffer Set (eBioscience) prior to 
intracellular staining. A subset of  fixed and permeabilized single cell suspensions were stimulated for 3 
hours with Cell Activation Cocktail containing phorbol-12-myristate 13-acetate (40.5 μM), ionomycin 
(660.3 μM), and Brefeldin A (2.5 mg/ml) in DMSO (all from BioLegend). Stimulated cells subsequently 
stained for lymphocyte populations and identification of  specific lymphocytes expressing AREG or KGF 
determined by flow cytometry using Biotin conjugated anti–mouse Kgf  (Biorbyt) and PE conjugated 
anti-mouse AREG (Biorbyt). Supplemental Table 4 lists antibody clones and catalog numbers for refer-
ence. Flow cytometry was performed using a Cytoflex flow cytometer (Beckman Coulter) and analyzed 
using CytExpert (Beckman Coulter) software.
Multicolor f low cytometric cell sorting. For Treg sorting, single cell digests from Foxp3EGFP mice were 
suspended in buffer (PBS with 1.6 % BSA; MilliporeSigma) containing 33% Percoll (MilliporeSig-
ma). The cell suspension was then centrifuged (931 g, 4°C, 20 minutes with low acceleration and 
deceleration), and the cell pellet containing lymphocytes was suspended in PBS with 1.6% BSA buf-
fer. The lymphocyte suspension was then Fc receptor blocked with rat anti–mouse FcγRIII/II recep-
tor (CD16/32; BD Pharmingen) and surface stained with Alexa 700 conjugated anti–mouse CD4 
(Supplemental Table 4). Cells were gated and sorted for CD4+GFP+ cells (Tregs) using a FACSAria 
instrument and FASCDiva software (Becton Dickinson), and they were analyzed using Flowjo (Tree 
Star Inc.) software. After sorting, Tregs were flash frozen in liquid nitrogen and later used for RNA 
purification and analysis.
RNA isolation and analysis. RNA was isolated from snap-frozen cells stored at –80°C using the Zymo 
Direct-zol RNA MiniPrep with TRI Reagent (Zymo Research) according to the manufacturer’s proto-
col with the following modifications: (a) snap-frozen cells were lysed in at least 125 μl of  TRI Reagent 
without thawing cells and (b) cells were centrifuged to collect debris or DNaseI-treated before applying 
to column. All samples were eluted in 25 μl of  DNase/RNase-Free water. The concentration of  RNA 
was determined using a NanoDrop 1000 (Thermo Fisher Scientific). The integrity of  the RNA was deter-
mined using Agilent RNA 6000 Nano chip (Agilent Technologies). RNA samples were concentrated at 
room temperature using an Eppendorf  Vacufuge 5301 (Eppendorf) until samples were 5 μl in volume for 
the array analyses. RNA was stored at –80°C before analysis.
RNA isolation and analysis for relative gene expression. RNA was isolated from snap-frozen cells stored at 
–80°C using the Zymo Direct-zol RNA MiniPrep with TRI Reagent according to the manufacturer’s proto-
col with the following modifications. Snap-frozen cells were lysed in at least 125 μl of  TRI Reagent without
thawing cells. Cells were not centrifuged to collect debris or DNaseI treated before applying to column. All
samples were eluted in 25 μl of  DNase/RNase-Free water. Concentrations of the RNA samples were deter-
mined with a NanoDrop 1000 (Thermo Fisher Scientific). SuperScript IV RT (Thermo Fisher Scientific)
was used for cDNA synthesis and digital droplet PCR reaction setup using ddPCR supermix for probes (no
dUTP) (Bio-Rad) according to the manufacturer’s protocol. Mouse Mmp12 HEX ddPCR primers and probe
were used in PCR reactions (Bio-Rad; 10042961). Droplets formed on Bio-Rad QX100 droplet generator per 
manufacturer’s protocol. The reactions then transferred to a 96-well PCR plate (Bio-Rad) and standard ther-
mocycling conditions were run on a SimpliAmp Thermal Cycler (Thermo Fisher Scientific). PCR droplet
reactions were then analyzed with a Bio-Rad QX100 Bio-Rad droplet reader and analyzed with QuantaSoft
Analysis Pro software (Bio-Rad).
mRNA profiling and data analysis and statistics. Expression of  mRNA transcripts from Tregs isolated 
from lungs without injury (lung control), lungs at day 7 after LPS, and spleens at day 7 after LPS was 
profiled using the Affymetrix MoGene ST v2.1 microarrays performed by the UNC School of  Medicine 
Functional Genomics Core Facility (n = 3 replicates in each condition).
Normalized gene expression was derived from microarray CEL files using Affymetrix Power 
Tools (https://media.affymetrix.com/support/developer/powertools/changelog/index.html) and 
custom meta-probe set mappings based on ENSEMBL v91 gene annotation. Specifically, Affymetrix 
probe sets were consolidated to ENSEMBL gene identifiers, and signals of  probes from the CEL files 
were summarized to gene level using median polish, after RMA background adjustment, GC con-
tent correction, and quantile normalization, before log2 transformation. The normalized transcript 
expression data were used in PCA and clustering analysis and as input to Bioconductor R package, 
limma, for differential expression analysis by linear models (23, 24). Differentially expressed tran-
scripts were filtered as FDR < 0.05 and fold change > 2. For GSEA, the ROAST available from 
limma were used (27).
Accession code. The microarray data have been deposited into the Gene Expression Omnibus (http://
www.ncbi.nlm.nih.gov/geo/) as series GSE104088.
Statistics. Data other than gene or transcript expression were compared between conditions using 
Student t tests, Mann-Whitney rank sum test or 1-way ANOVA with Tukey’s multiple comparison test 
between conditions. Data are expressed as the mean ± SEM. Statistical analysis was performed using 
GraphPad Prism 7 software. Statistical difference was accepted at P < 0.05.
Study approval. Procedures were conducted using protocols approved by the UNC Animal Care and 
Use Committee.
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